Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that ...

Another northeast Indiana college is getting money to explore challenges and opportunities stemming from advances in ...

PHILADELPHIA, PA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Applications are now welcome for the National ...

Healthcare, retail and finance stocks could do well in 2026. See five picks that experts say could have major upside ...

Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...

Eli Lilly's oral GLP-1 candidate, orforglipron, won't earn approval as fast as the company expected. Meanwhile, a notable ...

"I was just enrolling the kids into summer camp," one mother told IndyStar. Lifelong Ransburg YMCA members react to the news ...

If you needed proof that Gordon Gekko's greed philosophy is alive and well in 2026, look no further than the pharmaceutical ...

It feels like a great rotation out of the Magnificent Seven has already kicked off just over a quarter ago. Undoubtedly, the ...